Concord Medical Services Holdings Limited (CCM) Revenue History
Annual and quarterly revenue from 2013 to 2024
Compound Annual Growth Rate (CAGR)
Loading revenue history...
CCM Revenue Growth
Revenue Breakdown (FY 2024)
CCM's revenue distribution by segment and geography for fiscal year 2024
By Product/Segment
By Geography
CCM Revenue Analysis (2013–2024)
As of May 8, 2026, Concord Medical Services Holdings Limited (CCM) generated trailing twelve-month (TTM) revenue of $365.8 million, reflecting moderate decline in growth of -8.3% year-over-year. The most recent quarter (Q2 2025) recorded $100.3 million in revenue, up 0.0% sequentially.
Looking at the longer-term picture, CCM's 5-year compound annual growth rate (CAGR) stands at +14.1%, indicating consistent double-digit revenue growth. The company achieved its highest annual revenue of $616.5 million in 2015.
Revenue diversification analysis shows CCM's business is primarily driven by Services and other revenues (80%), Medicine income (18%), and Equipment Leasing Revenues (2%). With over half of revenue concentrated in Services and other revenues, the company maintains significant focus in this area while developing other growth vectors.
When compared to Healthcare sector peers including RDNT (+11.5% YoY), USPH (+4.0% YoY), and AMSF (+7.8% YoY), CCM has underperformed the peer group in terms of revenue growth. Compare CCM vs RDNT →
CCM Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| CCMCurrent | $366M | -8.3% | +14.1% | -138.6% | |
 RDNT | $2.0B | +11.5% | +13.7% | 3.0% | |
 USPH | $781M | +4.0% | +13.0% | 10.3% | |
 AMSF | $317M | +7.8% | -1.3% | 18.6% | |
 ARAY | $459M | -7.9% | +3.7% | 1.7% | |
 MLAB | $241M | +4.1% | +15.4% | 6.8% |
CCM Historical Revenue Data (2013–2024)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | $384.0M | -28.6% | $-79,162,000 | -20.6% | $-532,160,000 | -138.6% |
| 2023 | $537.4M | +13.8% | $-76,608,000 | -14.3% | $-462,985,000 | -86.2% |
| 2022 | $472.1M | -2.8% | $-152,409,000 | -32.3% | $-525,048,000 | -111.2% |
| 2021 | $485.6M | +117.8% | $-56,897,000 | -11.7% | $-458,318,000 | -94.4% |
| 2020 | $223.0M | +12.4% | $13.1M | 5.9% | $-316,001,000 | -141.7% |
| 2019 | $198.4M | +3.9% | $-15,830,000 | -8.0% | $-437,294,000 | -220.5% |
| 2018 | $190.9M | -42.3% | $19.8M | 10.4% | $-299,243,000 | -156.8% |
| 2017 | $331.0M | -27.3% | $98.0M | 29.6% | $-211,856,000 | -64.0% |
| 2016 | $455.0M | -26.2% | $168.5M | 37.0% | $-168,626,000 | -37.1% |
| 2015 | $616.5M | +1.6% | $263.1M | 42.7% | $-5,743,000 | -0.9% |
See CCM's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs CCM Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare CCM vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonCCM — Frequently Asked Questions
Quick answers to the most common questions about buying CCM stock.
Is CCM's revenue growth accelerating or slowing?
CCM revenue declined -8.3% year-over-year, contrasting with the 5-year CAGR of +14.1%. TTM revenue fell to $366M. This reverses the prior growth trend.
What is CCM's long-term revenue growth rate?
Concord Medical Services Holdings Limited's 5-year revenue CAGR of +14.1% reflects the variable expansion pattern. Current YoY growth of -8.3% is below this long-term average.
How is CCM's revenue distributed by segment?
CCM reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2013-2024 are available for download. Segment mix reveals concentration and diversification trends.